ALLMedicine™ Adrenal Carcinoma Center

Jun 9th, 2022 - Reference Range Dehydroepiandrosterone (DHEA) can be measured with radioimmunoassay, liquid chromatography–mass spectrometry (LC-MS), or chemiluminescent techniques, and the reference range varies by the technique used. The reference ranges for DH...

Jun 9th, 2022 - Dehydroepiandrosterone (DHEA) can be measured with radioimmunoassay, liquid chromatography–mass spectrometry (LC-MS), or chemiluminescent techniques, and the reference range varies by the technique used. The reference ranges for DHEA concentration...

Jun 9th, 2022 - Reference Range Dehydroepiandrosterone (DHEA) can be measured with radioimmunoassay, liquid chromatography–mass spectrometry (LC-MS), or chemiluminescent techniques, and the reference range varies by the technique used. The reference ranges for DH...

Jun 1st, 2022 - Adrenocortical carcinoma is a rare malignancy (0.5-2 cases/million/year) with a poor prognosis. Hypercortisolism, virilization, and compressive features are among the common presentations of adrenocortical carcinoma. Hematuria is one of the rare i...

May 18th, 2022 - To date, the mechanisms underlying excess androgen production from steroid producing tissues have been unclear, but recent Genome Wide Association Studies (GWAS) have provided additional data in this regard. Initial GWAS data in a Han Chinese popu...

May 18th, 2022 - To date, the mechanisms underlying excess androgen production from steroid producing tissues have been unclear, but recent Genome Wide Association Studies (GWAS) have provided additional data in this regard. Initial GWAS data in a Han Chinese popu...

Feb 12th, 2021 - Background and introduction Metastasis is the main cause of death in cancer patients and often epithelial-to-mesenchymal transition (EMT) is advocated as the basic mechanism, although some limitations have been identified [1,2] Recently Fang and c...

Oct 18th, 2019 - 1. LOW RISK STUDY The low risk group of patients includes NB patients without MYCN amplification with or without life threatening symptoms in the following clinical situations: Children aged ≤ 18 months with localised neuroblastoma associated with...

Jan 18th, 2019 - One of the problems in managing adrenocortical tumors is the ability to distinguish between benign and malignant tumors, while needle biopsy is unable to distinguish between the two situations. Therefore, when imaging tests demonstrate a suspected...

Jul 3rd, 2019 - Adrenal tumors found incidentally on imaging tests that are either nonfunctioning or have mild cortisol excess are highly unlikely to grow significantly or to develop into cancer or Cushing syndrome, US and UK researchers have found. The results o...

Jun 6th, 2007 - Action Points Explain to interested patients that adrenocortical cancer is rare and has a very poor prognosis, even if surgery removes the cancer completely. Note that this retrospective study suggests that using Mitotane (Lysodren), which selecti...

May 5th, 2005 - Introduction Accessory spleen is a variation of spleen development.[1] The most common location of an accessory spleen is at the splenic hilum.[1,2,3] Wandering accessory spleens may mimic tumors, such as pancreatic tumor, adnexal tumor, abdominal...

May 5th, 2005 - Discussions There are variants of spleen development, such as splenic clefts, notches, lobulations, an accessory spleen, polysplenia, and wandering spleen.[1] When an accessory spleen wanders to another place, it may mimic some tumors. Adnexal tum...